Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

The N-K GM Series offers highly selective, eco-friendly antimicrobials free for everyone.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Methotrexate improved skin condition in 64% of patients with generalized granuloma annulare.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

The N-K GM Series offers highly selective, eco-friendly medicines targeting harmful microbes, free for personal use.

A new treatment for hair loss shows promise with fewer side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Mitochondrial genes help predict breast cancer outcomes and spread.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Promising cancer treatments were found, but the manufacturer closed.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Researchers created 10 new compounds similar to cercidin, which could lead to new antibiotics.